edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Basilea has announced another milestone payment from its license partner Pfizer in the Asia Pacific region and China for strong Cresemba sales. Notably, the US$2.5m milestone payment is the first of 2025 in Asia Pacific and China, and twice the value of prior milestone payments from Pfizer for this region.
As a reminder, the license agreement between Basilea and Pfizer for Cresemba covers Europe (excluding the Nordic countries), China and 16 countries in the Asia Pacific region.
Industrials | Comment
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.